|
1
|
Kerbel R and Folkman J: Clinical
translation of angiogenesis inhibitors. Nat Rev Cancer. 2:727–739.
2002. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tian T, Nan KJ, Wang SH, et al: PTEN
regulates angiogenesis and VEGF expression through
phosphatase-dependent and -independent mechanisms in HepG2 cells.
Carcinogenesis. 31:1211–1219. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hasan J, Shnyder SD, Bibby M, Double JA,
Bicknel R and Jayson GC: Quantitative angiogenesis assays in vivo -
a review. Angiogenesis. 7:1–16. 2004. View Article : Google Scholar
|
|
4
|
Stoletov K, Kato H, Zardouzian E, et al:
Visualizing extravasation dynamics of metastatic tumor cells. J
Cell Sci. 123:2332–2341. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ferrara N: VEGF and the quest for tumour
angiogenesis factors. Nat Rev Cancer. 2:795–803. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xuan H, Zhao J, Miao J, Li Y, Chu Y and Hu
F: Effect of Brazilian propolis on human umbilical vein endothelial
cell apoptosis. Food Chem Toxicol. 49:78–85. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Folkman J: Angiogenesis and apoptosis.
Semin Cancer Biol. 13:159–167. 2003. View Article : Google Scholar
|
|
8
|
Plate KH, Breier G, Weich HA, Mennel HD
and Risau W: Vascular endothelial growth factor and glioma
angiogenesis: coordinate induction of VEGF receptors, distribution
of VEGF protein and possible in vivo regulatory mechanisms. Int J
Cancer. 59:520–529. 1994. View Article : Google Scholar
|
|
9
|
Strickler JH and Hurwitz HI:
Bevacizumab-based therapies in the first-line treatment of
metastatic colorectal cancer. Oncologist. 17:513–524. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sandler AB, Johnson DH and Herbst RS:
Anti-vascular endothelial growth factor monoclonals in non-small
cell lung cancer. Clin Cancer Res. 10:4258s–4262s. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang JC, Haworth L, Sherry RM, et al: A
randomized trial of bevacizumab, an anti-vascular endothelial
growth factor antibody, for metastatic renal cancer. N Engl J Med.
349:427–434. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ferrara N, Hillan KJ, Gerber HP and
Novotny W: Discovery and development of bevacizumab, an anti-VEGF
antibody for treating cancer. Nat Rev Drug Discov. 3:391–400. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Scott BJ, Quant EC, McNamara MB, Ryg PA,
Batchelor TT and Wen PY: Bevacizumab salvage therapy following
progression in high-grade glioma patients treated with VEGF
receptor tyrosine kinase inhibitors. Neuro Oncol. 12:603–607. 2010.
View Article : Google Scholar
|
|
14
|
Gild ML, Bullock M, Robinson BG and
Clifton-Bligh R: Multikinase inhibitors: a new option for the
treatment of thyroid cancer. Nat Rev Endocrinol. 7:617–624. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bottsford-Miller JN, Coleman RL and Sood
AK: Resistance and escape from antiangiogenesis therapy: clinical
implications and future strategies. J Clin Oncol. 30:4026–4034.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Trowe T, Boukouvala S, Calkins K, et al:
EXEL-7647 inhibits mutant forms of ErbB2 associated with lapatinib
resistance and neoplastic transformation. Clin Cancer Res.
14:2465–2475. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Raghav N and Singh M: Design, synthesis
and docking studies of bischalcones based quinazoline-2(1H)-ones
and quinazoline-2(1H)-thiones derivatives as novel inhibitors of
cathepsin B and cathepsin H. Eur J Pharm Sci. 54:28–39. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bilbro J, Mart M and Kyprianou N:
Therapeutic value of quinazoline-based compounds in prostate
cancer. Anticancer Res. 33:4695–4700. 2013.PubMed/NCBI
|
|
19
|
Xu L and Russu WA: Molecular docking and
synthesis of novel quinazoline analogues as inhibitors of
transcription factors NF-κB activation and their anti-cancer
activities. Bioorg Med Chem. 21:540–546. 2013.PubMed/NCBI
|
|
20
|
Chatterjee N, Das S, Bose D, et al:
Exploring the anti-inflammatory activity of a novel
2-phenylquinazoline analog with protection against inflammatory
injury. Toxicol Appl Pharmacol. 264:182–191. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hour MJ, Huang LJ, Kuo SC, et al:
6-Alkylamino- and 2,3-dihydro-3′-methoxy-2-phenyl-4-quinazolinones
and related compounds: their synthesis, cytotoxicity, and
inhibition of tubulin polymerization. J Med Chem. 43:4479–4487.
2000.
|
|
22
|
Chiu YJ, Hour MJ, Lu CC, et al: Novel
quinazoline HMJ-30 induces U-2 OS human osteogenic sarcoma cell
apoptosis through induction of oxidative stress and up-regulation
of ATM/p53 signaling pathway. J Orthop Res. 29:1448–1456. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ren T, Qing Y, Dai N, et al:
Apurinic/apyrimidinic endonuclease 1 induced upregulation of
fibroblast growth factor 2 and its receptor 3 induces angiogenesis
in human osteosarcoma cells. Cancer Sci. 105:186–194. 2014.
View Article : Google Scholar
|
|
24
|
Wu PP, Liu KC, Huang WW, et al: Triptolide
induces apoptosis in human adrenal cancer NCI-H295 cells through a
mitochondrial-dependent pathway. Oncol Rep. 25:551–557.
2011.PubMed/NCBI
|
|
25
|
Yang JS, Hour MJ, Huang WW, Lin KL, Kuo SC
and Chung JG: MJ-29 inhibits tubulin polymerization, induces
mitotic arrest, and triggers apoptosis via cyclin-dependent kinase
1-mediated Bcl-2 phosphorylation in human leukemia U937 cells. J
Pharmacol Exp Ther. 334:477–488. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pan SL, Guh JH, Peng CY, et al: YC-1
[3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] inhibits
endothelial cell functions induced by angiogenic factors in vitro
and angiogenesis in vivo models. J Pharmacol Exp Ther. 314:35–42.
2005.
|
|
27
|
Chiang JH, Yang JS, Lu CC, et al: Newly
synthesized quinazolinone HMJ-38 suppresses angiogenetic responses
and triggers human umbilical vein endothelial cell apoptosis
through p53-modulated Fas/death receptor signaling. Toxicol Appl
Pharmacol. 269:150–162. 2013. View Article : Google Scholar
|
|
28
|
Kiriakidis S, Hogemeier O, Starcke S, et
al: Novel tempeh (fermented soyabean) isoflavones inhibit in vivo
angiogenesis in the chicken chorioallantoic membrane assay. Br J
Nutr. 93:317–323. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pyun BJ, Choi S, Lee Y, et al: Capsiate, a
nonpungent capsaicin-like compound, inhibits angiogenesis and
vascular permeability via a direct inhibition of Src kinase
activity. Cancer Res. 68:227–235. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pang X, Yi Z, Zhang X, et al:
Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth
by suppressing vascular endothelial growth factor receptor
2-mediated angiogenesis. Cancer Res. 69:5893–5900. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pang X, Yi Z, Zhang J, et al: Celastrol
suppresses angiogenesis-mediated tumor growth through inhibition of
AKT/mammalian target of rapamycin pathway. Cancer Res.
70:1951–1959. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chung JG, Yang JS, Huang LJ, et al:
Proteomic approach to studying the cytotoxicity of YC-1 on U937
leukemia cells and antileukemia activity in orthotopic model of
leukemia mice. Proteomics. 7:3305–3317. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang WW, Chiu YJ, Fan MJ, et al:
Kaempferol induced apoptosis via endoplasmic reticulum stress and
mitochondria-dependent pathway in human osteosarcoma U-2 OS cells.
Mol Nutr Food Res. 54:1585–1595. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lu CC, Yang JS, Chiang JH, et al: Novel
quinazolinone MJ-29 triggers endoplasmic reticulum stress and
intrinsic apoptosis in murine leukemia WEHI-3 cells and inhibits
leukemic mice. PLoS One. 7:e368312012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yodkeeree S, Sung B, Limtrakul P and
Aggarwal BB: Zerumbone enhances TRAIL-induced apoptosis through the
induction of death receptors in human colon cancer cells: Evidence
for an essential role of reactive oxygen species. Cancer Res.
69:6581–6589. 2009. View Article : Google Scholar
|
|
36
|
Prasad S, Yadav VR, Ravindran J and
Aggarwal BB: ROS and CHOP are critical for dibenzylideneacetone to
sensitize tumor cells to TRAIL through induction of death receptors
and downregulation of cell survival proteins. Cancer Res.
71:538–549. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Aggarwal BB, Bhardwaj U and Takada Y:
Regulation of TRAIL-induced apoptosis by ectopic expression of
antiapoptotic factors. Vitam Horm. 67:453–483. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Iwai A, Shiozaki T and Miyazaki T:
Relevance of signaling molecules for apoptosis induction on
influenza A virus replication. Biochem Biophys Res Commun.
441:531–537. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kannaiyan R, Shanmugam MK and Sethi G:
Molecular targets of celastrol derived from Thunder of God Vine:
potential role in the treatment of inflammatory disorders and
cancer. Cancer Lett. 303:9–20. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chiang JH, Yang JS, Lu CC, et al: Effect
of DNA damage response by quinazolinone analogue HMJ-38 on human
umbilical vein endothelial cells: Evidence for γH2A.X and
DNA-PK-dependent pathway. Hum Exp Toxicol. 33:590–601.
2014.PubMed/NCBI
|
|
41
|
Yang JS, Hour MJ, Kuo SC, Huang LJ and Lee
MR: Selective induction of G2/M arrest and apoptosis in HL-60 by a
potent anticancer agent, HMJ-38. Anticancer Res. 24:1769–1778.
2004.PubMed/NCBI
|
|
42
|
Lu CC, Yang JS, Chiang JH, et al:
Inhibition of invasion and migration by newly synthesized
quinazolinone MJ-29 in human oral cancer CAL 27 cells through
suppression of MMP-2/9 expression and combined down-regulation of
MAPK and AKT signaling. Anticancer Res. 32:2895–2903.
2012.PubMed/NCBI
|
|
43
|
Tozer GM, Kanthou C and Baguley BC:
Disrupting tumour blood vessels. Nat Rev Cancer. 5:423–435. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Portt L, Norman G, Clapp C, Greenwood M
and Greenwood MT: Anti-apoptosis and cell survival: a review.
Biochim Biophys Acta. 1813:238–259. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li JH, Kirkiles-Smith NC, McNiff JM and
Pober JS: TRAIL induces apoptosis and inflammatory gene expression
in human endothelial cells. J Immunol. 171:1526–1533. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Herr I and Debatin KM: Cellular stress
response and apoptosis in cancer therapy. Blood. 98:2603–2614.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zou W, Liu X, Yue P, et al: c-Jun
NH2-terminal kinase- mediated up-regulation of death receptor 5
contributes to induction of apoptosis by the novel synthetic
triterpenoid methyl-2-cyano-3,12-dioxooleana-1, 9-dien-28-oate in
human lung cancer cells. Cancer Res. 64:7570–7578. 2004. View Article : Google Scholar
|
